There are 594 resources available
62P - Firmonertinib (formerly furmonertinib) combined with anlotinib in patients with treatment-naive EGFR-mutant non-small cell lung cancer: Updated results from FOCUS-A study
Presenter: Baohui Han
Session: Poster Display session
63P - Osimertinib for patients with EGFRm non-small cell lung cancer: Analysis of the locally advanced/metastatic cohort (OSIREAL study)
Presenter: Delvys Rodriguez Abreu
Session: Poster Display session
64P - A real-world study of furmonertinib in uncommon EGFR mutated non-small cell lung cancer with central nervous system metastasis
Presenter: Shen Cun Fang
Session: Poster Display session
65P - Real-world treatment patterns among patients with advanced NSCLC treated with amivantamab
Presenter: David Waterhouse
Session: Poster Display session
66P - Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study
Presenter: Lin Wu
Session: Poster Display session
67P - A phase II study of sunvozertinib combined with anlotinib in EGFR-TKIs resistant EGFRm advanced NSCLC patients (WUKONG9)
Presenter: Jie Hu
Session: Poster Display session
68P - Survival impact of immunotherapy(IO) after chemo-failure in EGFR-mutated NSCLCA post-hoc analysis of the Orient-31 trial
Presenter: Ziming Li
Session: Poster Display session
69P - PET/fluorescence dual-modal tracing for targeted inhibition of RRM2 to overcome osimertinib resistance in lung cancer
Presenter: Jinyu Zhu
Session: Poster Display session
Resources:
Abstract
70P - Amivantamab monotherapy in patients with pre-treated NSCLC with EGFR Exon 20 insertion mutations: Real-world data on efficacy and safety from the Italian biomarker ATLAS database
Presenter: Antonio Passaro
Session: Poster Display session
71P - FIN-EGFRprint: A retrospective observational study to investigate treatments and outcomes in patients with epidermal growth factor receptor-mutated (EGFRm) advanced non-small cell lung cancer (aNSCLC) in Finland
Presenter: Lalli Nurmi
Session: Poster Display session